CTIS2023-504554-35-00进行中（未招募）1 期
Surgical treatment of large incisional hernia with botulinum toxin A injection: a double-blind randomized controlled trial - APHP220805
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients between 18 and 79 years, BMI < 35 kg/m², Midline anterior primary or recurrent IH (subxiphoidal to suprapubic), of width >= 10 cm, on the abdominopelvic CT without injection of contrast agent, performed in the 6 months before inclusion (EHS W3), IH without loss of domain, defined by the ratio: (volume of the peritoneal sac) / (total peritoneal volume) < 25%, on the abdominal CT without injection of contrast agent, performed in the 6 months before inclusion, Written informed consent, Scheduled surgery for an open IH repair, For female of childbearing potential: using highly effective contraception
排除标准
- •Other types of IH (lateral, groin, para-stomal, port-site), Ongoing skin infection or inflammation at the IH site or at the BTA injection site, Planned IH repair with slowly absorbable mesh, IH with loss of domain (volumetric ratio > 25%), Emergency IH surgery, ASA score > 3, Pregnancy or breastfeeding, Ongoing treatment with aminoglycosides, Patient with ongoing treatment with medicinal products that interfere with the transfer of an impulse from a nerve to a muscle, e.g. tubocurarine-type muscle relaxants that weaken the muscles, Patient with severe and uncontrolled cardiovascular diseases, Patient has received BTA within 12 weeks, Severe hemostasis disorder or non-weaning treatment with curative dose anticoagulant, Patients with a history of seizures, Active tobacco use (or cessation inferior to 3 months), Use of another investigational product within 6 months or 5 half-lives (whichever is longer), or currently participating in a prospective study with an investigational product, whether it concerns an experimental drug or a medical device, Patient not covered by social insurance, Patient under legal guardianship, Hypersensitivity to the active substance (Clostridium Botulinum neurotoxin type A) or to any of the excipients (Human albumin, sucrose), Generalized disorders of muscle activity (e.g. myasthenia gravis, Lambert-Eaton syndrome), peripheral motor neuropathic diseases (e.g. amyotrophic lateral sclerosis or motor neuropathy), facial nerve disorders, underlying neurological disorders) and history of dysphagia and aspiration), VHWG grades 3 or 4 for the risk of surgical site infection
研究者
相似试验
已完成
不适用
egative pressure therapy in large incisional hernia surgerySeroma, volume and time drainage, and complications in large incisional hernia postoperativeSurgeryHernia surgeryISRCTN31224450niversity Hospital Joan XXIII de Tarragona (Spain)26
招募中
不适用
Treatment of strongulated inguinal hernia : Bassini versus Lichtenstein, HIERP trialSurgeryPACTR202010795072235Habib Bourguiba universal hospital78
已完成
不适用
Optimisation of incision hernia surgery treatmentDigestive SystemHerniaISRCTN45000842Kaunas Medical University Hospital (Lithuania) - Department of Surgery150
尚未招募
不适用
Study to compare management of Incisional Hernia by two different types of mesh repairCTRI/2020/04/024677Department of General Surgery
已完成
不适用
Mesh Hernioplasty Of Strangulated Hernias With Intestinal Resection .strangulated herniaJPRN-UMIN000006083mansoura university163